Editas Medicine, Inc. Income Statement

Income Statement Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 1.63M6.05M13.73M31.94M20.53M90.73M25.54M19.71M78.12M32.31M
Gross Profit 1.63M6.05M13.73M31.94M20.53M90.73M25.54M19.71M78.12M32.31M
Operating items
Research & Development 18.85M56.98M83.16M90.65M96.90M158.00M142.51M174.96M177.65M199.25M
Selling, General & Administrative 18.09M46.26M50.50M55.01M64.56M67.58M76.18M70.70M69.65M71.99M
Restructuring Costs 12.23M
Operating Expenses 36.94M103.24M133.66M145.66M161.45M225.57M218.69M245.66M247.30M283.47M
Operating Income -35.31M-97.19M-119.93M-113.73M-140.92M-134.84M-193.15M-225.95M-169.18M-251.15M
EBIT -35.31M-97.19M-119.93M-113.73M-140.92M-134.84M-193.15M-225.95M-169.18M-251.15M
Non-operating items
Interest & Investment Income -0.14M0.06M-0.98M3.44M7.31M2.60M0.61M5.52M17.57M14.06M
Other Non Operating Income -37.45M-0.06M0.59M0.33M-0.14M16.26M0.04M-1.60M-0.00M
Non Operating Income -37.59M-0.06M0.59M3.77M7.18M18.86M0.64M5.52M15.96M14.06M
Net income details
EBT -35.45M-97.13M-120.91M-110.28M-133.61M-132.24M-192.54M-220.43M-151.62M-237.09M
Profit After Tax -72.90M-97.18M-120.32M-109.95M-133.75M-115.98M-192.50M-220.43M-153.22M-237.09M
Income from Continuing Operations -35.45M-97.13M-120.91M-110.28M-133.61M-132.24M-192.54M-220.43M-151.62M-237.09M
Consolidated Net Income -35.45M-97.13M-120.91M-110.28M-133.61M-132.24M-192.54M-220.43M-151.62M-237.09M
Income towards Parent Company -35.45M-97.13M-120.91M-110.28M-133.61M-132.24M-192.54M-220.43M-151.62M-237.09M
Preferred Dividend Payments 0.39M0.05M
Net Income towards Common Stockholders -73.29M-97.23M-120.32M-109.95M-133.75M-115.98M-192.50M-220.43M-151.62M-237.09M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 36.61M35.61M46.88M47.81M51.30M62.33M68.40M68.76M81.67M82.55M
Shares Outstanding (Diluted Average) 49.98M58.61M67.62M68.66M75.97M82.34M
EBITDA -35.31M-97.19M-119.93M-113.73M-140.92M-134.84M-193.15M-225.95M-169.18M-251.15M
Shares Outstanding 3.23M35.82M44.51M48.76M54.36M62.56M68.44M68.85M81.77M82.73M